טוען...

Integrated Molecular Analysis of Tamoxifen-Resistant Invasive Lobular Breast Cancer Cells Identifies MAPK and GRM/mGluR Signaling as Therapeutic Vulnerabilities

Invasive lobular breast cancer (ILC) is an understudied malignancy with distinct clinical, pathological, and molecular features that distinguish it from the more common invasive ductal carcinoma (IDC). Mounting evidence suggests that estrogen receptor-alpha positive (ER+) ILC has a poor response to...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Mol Cell Endocrinol
Main Authors: Stires, Hillary, Heckler, Mary M., Fu, Xiaoyong, Zhao, Li, Grasso, Catherine S., Quist, Michael J., Lewis, Joseph A., Klimach, Uwe, Zwart, Alan, Mahajan, Akanksha, Győrffy, Balázs, Cavalli, Luciane R., Riggins, Rebecca B.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2017
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5858970/
https://ncbi.nlm.nih.gov/pubmed/28935545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mce.2017.09.024
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!